Children's Oncology Group's 2023 blueprint for research: Pediatric liver tumors

被引：4
作者：
O'Neill, Allison F. [1 ,2 ]
Meyers, Rebecka L. [3 ]
Katzenstein, Howard M. [4 ]
Geller, James, I [5 ]
Tiao, Greg M. [6 ]
Lopez-Terrada, Dolores [7 ]
Malogolowkin, Marcio [8 ]
机构：
[1] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Utah, Div Pediat Surg, Salt Lake City, UT USA
[4] Nemours Childrens Hosp, Wilmington, DE USA
[5] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH USA
[6] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Surg, Cincinnati, OH USA
[7] Texas Childrens Hosp & Canc Ctr, Baylor Coll Med, Dept Pathol & Immunol, Houston, TX USA
[8] Univ Calif Davis, Comprehens Canc Ctr, Pediat Oncol, Sacramento, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
hepatoblastoma; hepatocellular; international; liver; pediatric; PRETREATMENT PROGNOSTIC-FACTORS; HIGH-RISK HEPATOBLASTOMA; INDUCED HEARING-LOSS; JAPANESE-STUDY-GROUP; INTERNATIONAL-SOCIETY; HEPATOCELLULAR-CARCINOMA; CHILDHOOD HEPATOBLASTOMA; SODIUM THIOSULFATE; GENOMIC ANALYSIS; CANCER GROUP;
D O I：
10.1002/pbc.30576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Liver tumors account for approximately 1%-2% of all pediatric malignancies, with the two most common tumors being hepatoblastoma (HB) and hepatocellular carcinoma (HCC). Previous Children's Oncology Group studies have meaningfully contributed to the current understanding of disease pathophysiology and treatment, laying groundwork for the ongoing prospective international study of both HB and HCC. Future work is focused on elucidating the biologic underpinnings of disease to support an evolution in risk categorization, advancements in the multidimensional care required to treat these patients, and the discovery of novel therapies.
引用
收藏
页数：12
相关论文
共 87 条
  • [1] Unraveling the Genetic Architecture of Hepatoblastoma Risk: Birth Defects and Increased Burden of Germline Damaging Variants in Gastrointestinal/Renal Cancer Predisposition and DNA Repair Genes
    Aguiar, Talita
    Teixeira, Anne
    Scliar, Marilia O.
    Sobral de Barros, Juliana
    Lemes, Renan B.
    Souza, Silvia
    Tolezano, Giovanna
    Santos, Fernanda
    Tojal, Israel
    Cypriano, Monica
    Caminada de Toledo, Silvia Regina
    Valadares, Eugenia
    Borges Pinto, Raquel
    Pinto Artigalas, Osvaldo Afonso
    Caetano de Aguirre Neto, Joaquim
    Novak, Estela
    Cristofani, Lilian Maria
    Miura Sugayama, Sofia M.
    Odone, Vicente
    Cunha, Isabela Werneck
    Lima da Costa, Cecilia Maria
    Rosenberg, Carla
    Krepischi, Ana
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [2] Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study
    Aronson, DC
    Schnater, JM
    Staalman, CR
    Weverling, GJ
    Plaschkes, J
    Perilongo, G
    Brown, J
    Phillips, A
    Otte, JB
    Czauderna, P
    MacKinlay, G
    Vos, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1245 - 1252
  • [3] Impact of Postoperative Complications on Overall Survival of Patients With Hepatoblastoma
    Becker, Kristina
    Furch, Christiane
    Schmid, Irene
    von Schweinitz, Dietrich
    Haeberle, Beate
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (01) : 24 - 28
  • [4] Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT)
    Boster, Julia M.
    Superina, Riccardo
    Mazariegos, George, V
    Tiao, Gregory M.
    Roach, Jonathan P.
    Lovell, Mark A.
    Greffe, Brian S.
    Yanni, George
    Leung, Daniel H.
    Elisofon, Scott A.
    McDiarmid, Suzanne, V
    Gupta, Nitika A.
    Lobritto, Steven J.
    Lemoine, Caroline
    Stoll, Janis M.
    Vitola, Bernadette E.
    Daniel, James F.
    Sayed, Blayne A.
    Desai, Dev M.
    Martin, Abigail E.
    Amin, Arpit
    Anand, Ravinder
    Anderson, Sarah G.
    Sundaram, Shikha S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (05) : 1396 - 1408
  • [5] Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
    Braman, Nathaniel M.
    Etesami, Maryam
    Prasanna, Prateek
    Dubchuk, Christina
    Gilmore, Hannah
    Tiwari, Pallavi
    Pletcha, Donna
    Madabhushi, Anant
    [J]. BREAST CANCER RESEARCH, 2017, 19
  • [6] Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
    Brock, P. R.
    Maibach, R.
    Childs, M.
    Rajput, K.
    Roebuck, D.
    Sullivan, M. J.
    Laithier, V.
    Ronghe, M.
    Dall'Igna, P.
    Hiyama, E.
    Brichard, B.
    Skeen, J.
    Mateos, M. E.
    Capra, M.
    Rangaswami, A. A.
    Ansari, M.
    Rechnitzer, C.
    Veal, G. J.
    Covezzoli, A.
    Brugieres, L.
    Perilongo, G.
    Czauderna, P.
    Morland, B.
    Neuwelt, E. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25) : 2376 - 2385
  • [7] Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1
    Brown, J
    Perilongo, G
    Shafford, E
    Keeling, J
    Pritchard, J
    Brock, P
    Dicks-Mireaux, C
    Phillips, A
    Vos, A
    Plaschkes, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) : 1418 - 1425
  • [8] Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer
    Cairo, Stefano
    Wang, Yipeng
    de Reynies, Aurelien
    Duroure, Karine
    Dahan, Jennifer
    Redon, Marie-Jose
    Fabre, Monique
    McClelland, Michael
    Wang, Xin W.
    Croce, Carlo M.
    Buendia, Marie-Annick
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (47) : 20471 - 20476
  • [9] Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
    Cairo, Stefano
    Armengol, Carolina
    De Reynies, Auelien
    Wei, Yu
    Thomas, Emilie
    Renard, Claire-Angelique
    Goga, Andrei
    Balakrishnan, Asha
    Semeraro, Michaela
    Gresh, Lionel
    Pontoglio, Marco
    Strick-Marchand, Helene
    Levillayer, Florence
    Nouet, Yann
    Rickman, David
    Gauthier, Frederic
    Branchereau, Sophie
    Brugieres, Laurence
    Laithier, Veronique
    Bouvier, Raymonde
    Boman, Francoise
    Basso, Giuseppe
    Michiels, Jean-Francois
    Hofman, Paul
    Arbez-Gindre, Francine
    Jouan, Helene
    Chapeau, Marie-Christine Rousselet
    Berrebi, Dominique
    Marcellin, Luc
    Plenat, Francois
    Zachar, Dominique
    Joubert, Madeleine
    Selves, Janick
    Pasquier, Dominique
    Bioulac-Sage, Paulette
    Grotzer, Michael
    Childs, Margaret
    Fabre, Monique
    Buendia, Marie-Annick
    [J]. CANCER CELL, 2008, 14 (06) : 471 - 484
  • [10] Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
    Carrillo-Reixach, Juan
    Torrens, Laura
    Simon-Coma, Marina
    Royo, Laura
    Domingo-Sabat, Montserrat
    Abril-Fornaguera, Jordi
    Akers, Nicholas
    Sala, Margarita
    Ragull, Sonia
    Arnal, Magdalena
    Villalmanzo, Nuria
    Cairo, Stefano
    Villanueva, Alberto
    Kappler, Roland
    Garrido, Marta
    Guerra, Laura
    Sabado, Constantino
    Guillen, Gabriela
    Mallo, Mar
    Pineyro, David
    Vazquez-Vitali, Maria
    Kuchuk, Olga
    Elena Mateos, Maria
    Ramirez, Gema
    Lopez Santamaria, Manuel
    Mozo, Yasmina
    Soriano, Aroa
    Grotzer, Michael
    Branchereau, Sophie
    Garcia de Andoin, Nagore
    Lopez-Ibor, Blanca
    Lopez-Almaraz, Ricardo
    Antonio Salinas, Jose
    Torres, Barbara
    Hernandez, Francisco
    Javier Uriz, Jose
    Fabre, Monique
    Blanco, Julia
    Paris, Claudia
    Bajciova, Viera
    Laureys, Genevieve
    Masnou, Helena
    Clos, Ariadna
    Belendez, Cristina
    Guettier, Catherine
    Sumoy, Lauro
    Planas, Ramon
    Jorda, Mireia
    Nonell, Lara
    Czauderna, Piotr
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 328 - 341
123456789